Drugs / DLI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01497184 | Dec 2011 → Mar 2021 | leukemia, lymphoma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DLI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01497184 ↗ |
| Route | Intravenous | “Allogeneic donor lymphocyte infusion (DLI) starting dose not to exceed 10\^6/m\^2 intravenously” NCT01497184 ↗ |